开拓治疗前沿

开拓治疗前沿

我们的任务

利用我们革命性的 platON™ 平台改变癌症和炎症性疾病的治疗方法

无限可能

Valerio Therapeutics 是一家临床阶段生物技术公司,设计和开发针对细胞内 DNA 结合靶点的新型肿瘤药物。
我们的方法基于 DNA 诱饵疗法的独特作用机制,用于精准肿瘤治疗。

战略合作伙伴关系

我们的合作伙伴关系使我们优于其他治疗公司,利用我们独特的治疗方法来多样化地提供改变生活的益处。

强大的专业知识和清晰的战略

Clinical Expertise
Licensing Agreements
World-class Advisors

Unique Science

Creating Innovative Compounds
Distinctive Mechanisms
Addressing New & Multiple Pathways

DNA Decoy Therapeutics

First-in-class product in DDR currently in clinical trials
Only decoy agonist in development

Latest News

  • Valerio Therapeutics: 16.8 million euros in cash, visibility until the 2nd quarter of 2024
    Valerio Therapeutics: 16.8 million euros in cash, visibility until the 2nd quarter of 2024

    9月 29, 2023

  • Valerio Therapeutics: , largest increase in the SRD market at mid-session
    Valerio Therapeutics: , largest increase in the SRD market at mid-session

    8月 30, 2023

  • Le Journal des Biotechs | Interview of Shefali Agarwal, President and CEO of Onxeo (in French)
    Le Journal des Biotechs | Interview of Shefali Agarwal, President and CEO of Onxeo (in French)

    4月 20, 2023